» Articles » PMID: 26828135

Global Trends in Incidence and Mortality of Nasopharyngeal Carcinoma

Overview
Journal Cancer Lett
Specialty Oncology
Date 2016 Feb 2
PMID 26828135
Citations 197
Authors
Affiliations
Soon will be listed here.
Abstract

Nasopharyngeal carcinoma (NPC) is a rare malignancy with an extraordinarily skewed geographic distribution worldwide. Although decreasing trends in incidence and mortality of NPC have been sporadically reported in some high-risk areas, no comprehensive description of the global trends has ever been made. We accessed incidence (1970-2007) and mortality (1970-2013) data from multiple sources, with the main ones being the Cancer Incidence in Five Continents (CI5) series and the World Health Organization (WHO) cancer mortality database. During the entire period studied, age-standardized incidence rates (ASIRs) of NPC decreased significantly in southern and eastern Asia, north America and Nordic countries with average annual percent changes (AAPCs) of -0.9% to -5.4% in males and -1.1% to -4.1% in females. Declines in age-standardized mortality rates (ASMRs) are even more remarkable and extensive, with AAPCs varying from -0.9% and -0.8% to -3.7% and -6.5% in males and females, respectively. Decreasing trends in NPC incidence are probably due to tobacco control, changes in diets and economic development. Declines in mortality rates are the results of advancements in diagnostic and radiotherapy techniques, as well as decreased incidence rates.

Citing Articles

Transcriptomic profiling reveals mechanism, therapeutic potential, and prognostic value of cancer stemness characteristic in nasopharyngeal carcinoma.

Chen J, Shen R, Zhu J, Wang Y, Fu L, Chen Y Funct Integr Genomics. 2025; 25(1):56.

PMID: 40053129 DOI: 10.1007/s10142-025-01561-w.


Dermatomyositis as the First Manifestation of Nasopharyngeal Carcinoma-A Rare Case Report.

Knezevic B, Radevic T, Petronijevic M Medicina (Kaunas). 2025; 61(2).

PMID: 40005448 PMC: 11857375. DOI: 10.3390/medicina61020334.


Circulating tumor DNA in head and neck squamous cell carcinoma-current status and future prospects.

Auger S, Mishra V, Singh A, Miao Y, Agrawal N, Izumchenko E Acad Oncol. 2025; 1(2).

PMID: 39867572 PMC: 11760339. DOI: 10.20935/acadonco7456.


Unveiling the complex double-edged sword role of exosomes in nasopharyngeal carcinoma.

Huang X, Tang Y PeerJ. 2025; 13():e18783.

PMID: 39822977 PMC: 11737332. DOI: 10.7717/peerj.18783.


The multi-target mechanism of action of Selaginella doederleinii Hieron in the treatment of nasopharyngeal carcinoma: a network pharmacology and multi-omics analysis.

Liang H, Fang C, Qiu M Sci Rep. 2025; 15(1):159.

PMID: 39747499 PMC: 11695685. DOI: 10.1038/s41598-024-83921-3.